Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 494.50p on 18-08-2025 at 06:15:10
Change 0.00p 0%
Buy 500.00p
Sell 0.00p
Last Trade: Unknown 30,000.00 at 495.00p
Day's Volume: 0
Last Close: 494.50p
Open: 0.00p
ISIN: GB00BDFBVT43
Day's Range 0.00p - 0.00p
52wk Range: 232.50p - 496.50p
Market Capitalisation: £525.15m
VWAP: 0.00p
Shares in Issue: 106.20m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 30,000 495.00p Ordinary
17:28:58 - 15-Aug-25
Buy* 84,858 494.50p Suspected BUY Trade
16:35:10 - 15-Aug-25
Sell* 61 495.51099p SI Trade
Suspected SELL Trade
16:25:15 - 15-Aug-25
Sell* 1,000 497.08p Ordinary
16:25:13 - 15-Aug-25
Buy* 21 496.50p Automatic Execution
16:24:01 - 15-Aug-25
Buy* 179 496.50p Automatic Execution
16:24:01 - 15-Aug-25
Buy* 835 495.767p Suspected BUY Trade
16:23:56 - 15-Aug-25
Buy* 52 495.50p Automatic Execution
16:23:56 - 15-Aug-25
Buy* 263 495.50p Automatic Execution
16:23:56 - 15-Aug-25
Buy* 282 495.50p Automatic Execution
16:23:56 - 15-Aug-25
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
15th Aug 2025 (Fri) 451.50 496.50 442.00 494.50 566,978
14th Aug 2025 (Thu) 442.00 447.50 439.00 439.50 100,312
13th Aug 2025 (Wed) 443.50 445.50 440.50 444.00 134,702
12th Aug 2025 (Tue) 430.00 448.00 430.00 443.00 125,466
11th Aug 2025 (Mon) 450.00 450.00 430.00 430.00 137,733
8th Aug 2025 (Fri) 430.00 443.00 430.00 440.50 80,005
7th Aug 2025 (Thu) 445.50 456.00 436.50 442.50 134,403
6th Aug 2025 (Wed) 465.00 465.00 455.50 459.50 93,016
5th Aug 2025 (Tue) 470.00 470.00 455.00 460.00 102,688
4th Aug 2025 (Mon) 450.50 470.50 449.00 462.50 149,384
1st Aug 2025 (Fri) 455.00 464.50 418.00 464.50 269,333
31st Jul 2025 (Thu) 459.00 459.00 442.00 458.50 176,752
30th Jul 2025 (Wed) 439.50 458.50 433.00 458.50 156,349
29th Jul 2025 (Tue) 414.00 440.00 412.00 440.00 279,976
28th Jul 2025 (Mon) 390.00 420.00 387.00 412.00 540,932
25th Jul 2025 (Fri) 388.50 389.50 380.00 383.00 66,975
24th Jul 2025 (Thu) 383.00 390.00 383.00 386.50 100,628
23rd Jul 2025 (Wed) 375.00 385.00 371.00 383.00 119,549
22nd Jul 2025 (Tue) 367.50 375.00 367.50 374.00 56,598
21st Jul 2025 (Mon) 369.50 375.00 368.50 375.00 96,278
18th Jul 2025 (Fri) 370.00 370.00 359.00 370.00 35,244
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
15th Aug 2025 1:45 pm RNS PDMR Dealings
15th Aug 2025 7:05 am RNS Results of Placing
14th Aug 2025 5:02 pm RNS Proposed Placing of New Ordinary Shares
1st Aug 2025 7:00 am RNS OXB Secures New Loan Facility with Oaktree
1st Aug 2025 7:00 am RNS Total Voting Rights
28th Jul 2025 7:00 am RNS Half Year Trading Update
2nd Jul 2025 7:00 am RNS Director Declaration
1st Jul 2025 7:00 am RNS Block listing Interim Review
1st Jul 2025 7:00 am RNS Total Voting Rights
23rd Jun 2025 7:00 am RNS OXB completes acquisition of US subsidiary
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

Oxford BioMedica raises GBP60 million to fund US expansion

15th Aug 2025 15:59

(Alliance News) - Oxford BioMedica PLC on Friday said it has raised GBP60 million through a share placing and subscription to support expansion in the US and boost process productivity. Read More

SMALL-CAP WINNERS: Oxford BioMedica fundraise nets about GBP60 million

15th Aug 2025 10:41

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

IN BRIEF: Oxford Biomedica to refinance debt with USD125 million loan

1st Aug 2025 12:52

Oxford Biomedica PLC - Oxford, England-based gene and cell therapy developer - Says it has a new loan facility with Oaktree Capital Management LP worth up to USD125 million over four years. Expects USD60 million upfront funding to be available when the deal closes. Plans to use this to repay an existing USD50 million loan from Oaktree. Notes that the loan includes option to draw down further USD25 million and additional USD40 million, subject to revenue targets. Says this increases flexibility to grow global contract development and manufacturing operations. Notes also that the loan will not amortise, with the full aggregate principal and outstanding amount due in 2029. Read More

SMALL-CAP WINNERS & LOSERS: Ceres gets Korea boost; STV takes ad hit

28th Jul 2025 10:40

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

Oxford BioMedica holds outlook as revenue jumps and order book boosted

28th Jul 2025 09:33

(Alliance News) - Oxford BioMedica PLC on Monday said it expects to report a jump in revenue in the first half of the year as its order book more than doubled. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value9,138.90
Change0.00

Login to your account

Forgot Password?

Not Registered